Cefoperazone Sodium Salt: From Mechanism to Models
2026-08-18
Cefoperazone sodium salt is more than a broad-spectrum cephalosporin reference compound: it is a practical probe for studying β-lactamase stability, antibacterial activity against gram-negative bacilli, and the translation of susceptibility data into infection models. This article connects comparative evidence with experimental design, biliary distribution, and strategic use in gram-negative bacterial resistance research.
A-1331852: Mapping BCL-XL-Dependent Apoptosis
2026-08-17
A-1331852 is a selective BCL-XL inhibitor for dissecting mitochondrial apoptosis, cellular dependency, and chemotherapy-induced senescence. This article translates key findings from a landmark BH3-mimetic study into a rigorous strategy for designing and interpreting apoptosis assays.
Thermal-Protective Hydrogel for Tumor Ablation
2026-08-17
The reference study presents MR@CaP@HA, an injectable hydrogel that combines local thermal insulation with pH- and glutathione-responsive delivery of mitoxantrone and Resiquimod (R-848). In an image-guided ablation setting, the platform protected adjacent tissue, promoted immunogenic tumor-cell death and immune remodeling, and produced complete tumor eradication in a subset of treated animals.
Morin: Neuroprotection and Assay Workflows
2026-08-16
Morin combines flavonoid bioactivity with fluorescent metal-chelation capability, enabling one research reagent to support oxidative-stress, mitochondrial, inflammation, and aluminum-detection workflows. This guide translates those properties into practical dose-response designs, phenotype-focused neurobiology assays, and troubleshooting strategies while keeping clinical claims appropriately bounded.
Salinomycin Assay Design Guide
2026-08-15
Learn how Salinomycin (SKU A3785) can improve the interpretation, solvent handling, and reproducibility of hepatocellular carcinoma viability and apoptosis assays. This scenario-based guide separates growth inhibition from cell killing and translates product specifications into practical laboratory decisions.
Carrier-Platin and ROS-Driven Cancer Cell Death
2026-08-15
Liu and colleagues developed carrier-platin, a poly(amino acids)-based platform that confines ultrasmall platinum nanoparticles and rapidly amplifies intracellular reactive oxygen species. The study reports a DNA-damage-independent death program distinct from apoptosis and ferroptosis, with activity against multidrug-resistant cancers and limited systemic toxicity in the tested models.
Bazedoxifene and IL-6/GP130 Signaling in Cancer
2026-08-14
This 2024 review highlights Bazedoxifene, an established selective estrogen receptor modulator, as a potential inhibitor of IL-6/GP130 signaling and a candidate for cancer drug repurposing. Its synthesis of computational, cellular, and combination-therapy evidence provides a framework for testing pathway dependence while emphasizing that clinical oncology efficacy remains unestablished.
LDH Cytotoxicity Assay Kit for Nanocompatibility
2026-08-14
Use LDH release as a practical, non-radioactive endpoint for comparing nanomaterial formulations, magnetic-hyperthermia conditions, and cell injury. This workflow combines essential controls, interference checks, and reference-backed design choices for more reliable cell cytotoxicity measurement.
LRPPRC–Dasatinib Synergy Disrupts Tumor OXPHOS
2026-08-13
A 2026 study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. The combination produces complementary suppression of mitochondrial- and nuclear-encoded OXPHOS programs, providing a mechanistic rationale for dual-genome metabolic targeting.
3X FLAG Peptide: From Tag to Assay Control
2026-08-13
The 3X (DYKDDDDK) Peptide is more than a high-sensitivity epitope reagent: it can serve as a controllable interface for purification, detection, structural biology, and assay validation. This article connects its chemistry to practical decisions inspired by mechanistic findings in Legionella effector research.
Gut Dysbiosis and α-Synuclein Pathology in PD
2026-08-12
This study shows that gut microbiota dysbiosis is not merely associated with rotenone-induced Parkinsonian pathology but is required for the observed intestinal, inflammatory, and nigrostriatal abnormalities in mice. Antibiotic-mediated microbiome depletion and fecal microbiota transplantation identify the gut microbiota as an upstream regulator of C/EBPβ/AEP signaling, α-synuclein aggregation, and motor dysfunction.
GLI2, WNT, and Prostaglandins in Immunotherapy Resistance
2026-08-12
The reference study identifies GLI2 as a mechanistic link between mesenchymal transformation and an immunosuppressive tumor microenvironment. Its findings show that GLI2 coordinates WNT ligand production and prostaglandin signaling, thereby promoting myeloid suppression and resistance to anti-PD-1 therapy.
Tubastatin A Alleviates Post-Resuscitation Injury
2026-08-11
A 2025 porcine study found that Tubastatin A reduced cardiac dysfunction and myocardial injury after cardiac arrest and resuscitation. The protection was associated with lower GSDME-mediated pyroptosis, MLKL-mediated necroptosis, apoptosis-related signals, and inflammatory mediators, although the mechanism remains pharmacologically suggestive rather than proven.
DiI (DiIC18(3)) Membrane Probe Guide
2026-08-10
DiI (DiIC18(3)) provides orange fluorescent labeling of plasma membranes for live or fixed-cell imaging, neuronal tracing, migration studies, and membrane-associated assays. It requires an organic solvent for stock preparation and is not suitable for aqueous-only staining or organelle-specific labeling.
Ferroptosis Inducers in Advanced Prostate Cancer
2026-08-09
Ghoochani and colleagues provide a preclinical evaluation of ferroptosis induction in treatment-resistant prostate cancer, showing activity for erastin and RSL3 both alone and with second-generation anti-androgens. The study connects expression of SLC7A11, SLC3A2, and GPX4 with a therapeutically relevant vulnerability and supplies a rationale for testing redox-directed treatments in advanced disease models.
458 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page